Agilent Technologies (NYSE:A) Price Target Raised to $185.00

Agilent Technologies (NYSE:A) had its target price boosted by investment analysts at Royal Bank Of Canada from $155.00 to $185.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the medical research company’s stock. Royal Bank Of Canada’s target price would indicate a potential upside of 17.03% from the company’s current price.

Several other research firms have also weighed in on A. Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. HSBC decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Sanford C. Bernstein initiated coverage on Agilent Technologies in a research report on Friday, June 26th. They set an “outperform” rating and a $155.00 price target on the stock. Jefferies Financial Group began coverage on Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price target for the company. Finally, Morgan Stanley lifted their price objective on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $162.12.

Agilent Technologies Trading Up 1.9%

Shares of NYSE A traded up $3.00 during midday trading on Thursday, hitting $158.08. The stock had a trading volume of 683,712 shares, compared to its average volume of 2,225,178. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. Agilent Technologies has a 1-year low of $108.35 and a 1-year high of $163.75. The company has a market capitalization of $44.65 billion, a price-to-earnings ratio of 31.60, a PEG ratio of 2.73 and a beta of 1.25. The company has a fifty day moving average price of $139.16 and a 200 day moving average price of $126.65.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. During the same period in the previous year, the company posted $1.37 earnings per share. Agilent Technologies’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts predict that Agilent Technologies will post 6.05 earnings per share for the current year.

Institutional Trading of Agilent Technologies

A number of hedge funds and other institutional investors have recently modified their holdings of A. SHP Wealth Management purchased a new position in Agilent Technologies in the fourth quarter valued at about $26,000. Core Wealth Advisors LLC purchased a new stake in Agilent Technologies during the 4th quarter worth approximately $26,000. Navalign LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at approximately $27,000. Markowski Investments acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at approximately $27,000. Finally, MV Capital Management Inc. purchased a new position in shares of Agilent Technologies during the 4th quarter valued at approximately $28,000. 87.41% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported third-quarter revenue of $1.88 billion, up 8.1% year over year and above the $1.84 billion consensus estimate. Adjusted EPS was $1.62, ahead of the $1.49 analyst expectation and up from $1.37 a year earlier. GAAP net income increased to $362 million, or $1.28 per share. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Management raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the $6.06 consensus, and expects approximately $7.5 billion in revenue. The improved outlook reflects better demand for tools used in laboratory research, drug development and related applications. Agilent raises annual profit forecast on improving lab tools demand
• Positive Sentiment: Results pointed to operating leverage, with operating profit reportedly rising faster than revenue and margins expanding. Cash flow was also strong, supporting Agilent’s financial flexibility and reinforcing the earnings-quality case. Agilent Technologies: Q3 Growth, Expanding Margins, And Raised Guidance
• Neutral Sentiment: Fourth-quarter adjusted EPS guidance of $1.71-$1.74 is centered around the analyst consensus, while expected revenue of approximately $2.0 billion is broadly in line. This suggests the main upside catalyst came from the third-quarter beat and full-year upgrade rather than a major near-term forecast increase. Agilent Boosts FY View on Higher 3Q Profit, Revenue
• Neutral Sentiment: Institutional ownership changes were mixed, and the shares’ elevated valuation—about 31 times earnings—leaves less room for disappointment despite the stronger outlook.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.